Cargando…
Cx31.1 acts as a tumour suppressor in non-small cell lung cancer (NSCLC) cell lines through inhibition of cell proliferation and metastasis
Reduced connexin expression and loss of gap junction function is a characteristic of many cancers, including lung cancer. However, there are little reports about the relation between Cx31.1 and lung cancer. This study was conducted to investigate the effect of Cx31.1 on non-small cell lung cancer (N...
Autores principales: | Zhang, Deqiang, Chen, Chengwen, Li, Yuan, Fu, Xuping, Xie, Yi, Li, Yao, Huang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365884/ https://www.ncbi.nlm.nih.gov/pubmed/21777377 http://dx.doi.org/10.1111/j.1582-4934.2011.01389.x |
Ejemplares similares
-
Connexin 31.1 degradation requires the Clathrin-mediated autophagy in NSCLC cell H1299
por: Zhu, Xingli, et al.
Publicado: (2015) -
A Germline Variant on Chromosome 4q31.1 Associates with Susceptibility to Developing Colon Cancer Metastasis
por: Markowitz, Sanford D., et al.
Publicado: (2016) -
Chromosome 1p31.1 Deletion Syndrome: Limited Expression
por: Biswal, Seba, et al.
Publicado: (2021) -
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
por: Cai, Tingting, et al.
Publicado: (2020) -
Effects of miR-340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines
por: Zhu, Xidan, et al.
Publicado: (2019)